<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E34FA4DB-FD6C-4477-82AA-F9FFBC04D84D"><gtr:id>E34FA4DB-FD6C-4477-82AA-F9FFBC04D84D</gtr:id><gtr:name>Kiel University</gtr:name><gtr:address><gtr:line1>Kiel University</gtr:line1><gtr:line2>Christian Albrechts Platz 4</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4070BB4C-8B35-4D73-9FB7-91F3E12BC269"><gtr:id>4070BB4C-8B35-4D73-9FB7-91F3E12BC269</gtr:id><gtr:name>Fios Genomics</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BB8180F5-61D2-45F0-B245-44DA162A845B"><gtr:id>BB8180F5-61D2-45F0-B245-44DA162A845B</gtr:id><gtr:name>The Psoriasis Association</gtr:name><gtr:address><gtr:line1>Milton House</gtr:line1><gtr:line2>7 Milton Street</gtr:line2><gtr:postCode>NN2 7JG</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4EBF3DC3-B4A4-4E4E-B13D-284698AA70D7"><gtr:id>4EBF3DC3-B4A4-4E4E-B13D-284698AA70D7</gtr:id><gtr:name>Dana-Farber Cancer Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31721C5B-E0B8-4CBA-B506-078923F6B700"><gtr:id>31721C5B-E0B8-4CBA-B506-078923F6B700</gtr:id><gtr:name>Icosagen</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6"><gtr:id>0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6</gtr:id><gtr:name>Hebrew University of Jerusalem</gtr:name><gtr:address><gtr:line1>Mt Scopus</gtr:line1><gtr:line4>Jerusalem</gtr:line4><gtr:line5>91905</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CE713D42-FE8A-4117-AB3C-224D5A93265A"><gtr:id>CE713D42-FE8A-4117-AB3C-224D5A93265A</gtr:id><gtr:name>Heinrich Heine University D?sseldorf</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DF79FD97-AFC0-4E12-B081-3BF8E8ABCB2C"><gtr:id>DF79FD97-AFC0-4E12-B081-3BF8E8ABCB2C</gtr:id><gtr:name>Wellcome Trust Case Control Consortium 2 (WTCCC)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Genetics and Molecular Medicine</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E34FA4DB-FD6C-4477-82AA-F9FFBC04D84D"><gtr:id>E34FA4DB-FD6C-4477-82AA-F9FFBC04D84D</gtr:id><gtr:name>Kiel University</gtr:name><gtr:address><gtr:line1>Kiel University</gtr:line1><gtr:line2>Christian Albrechts Platz 4</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4070BB4C-8B35-4D73-9FB7-91F3E12BC269"><gtr:id>4070BB4C-8B35-4D73-9FB7-91F3E12BC269</gtr:id><gtr:name>Fios Genomics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BB8180F5-61D2-45F0-B245-44DA162A845B"><gtr:id>BB8180F5-61D2-45F0-B245-44DA162A845B</gtr:id><gtr:name>The Psoriasis Association</gtr:name><gtr:address><gtr:line1>Milton House</gtr:line1><gtr:line2>7 Milton Street</gtr:line2><gtr:postCode>NN2 7JG</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4EBF3DC3-B4A4-4E4E-B13D-284698AA70D7"><gtr:id>4EBF3DC3-B4A4-4E4E-B13D-284698AA70D7</gtr:id><gtr:name>Dana-Farber Cancer Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31721C5B-E0B8-4CBA-B506-078923F6B700"><gtr:id>31721C5B-E0B8-4CBA-B506-078923F6B700</gtr:id><gtr:name>Icosagen</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6"><gtr:id>0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6</gtr:id><gtr:name>Hebrew University of Jerusalem</gtr:name><gtr:address><gtr:line1>Mt Scopus</gtr:line1><gtr:line4>Jerusalem</gtr:line4><gtr:line5>91905</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CE713D42-FE8A-4117-AB3C-224D5A93265A"><gtr:id>CE713D42-FE8A-4117-AB3C-224D5A93265A</gtr:id><gtr:name>Heinrich Heine University D?sseldorf</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DF79FD97-AFC0-4E12-B081-3BF8E8ABCB2C"><gtr:id>DF79FD97-AFC0-4E12-B081-3BF8E8ABCB2C</gtr:id><gtr:name>Wellcome Trust Case Control Consortium 2 (WTCCC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C8C844DC-62CE-4F77-8AF8-CDB32543E6FA"><gtr:id>C8C844DC-62CE-4F77-8AF8-CDB32543E6FA</gtr:id><gtr:firstName>Adrian</gtr:firstName><gtr:surname>Hayday</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AB28FFD0-BF24-463C-A3F1-27E8DF99B613"><gtr:id>AB28FFD0-BF24-463C-A3F1-27E8DF99B613</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Trembath</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/259A9C4C-8DF6-48F9-B626-B414032F4DC8"><gtr:id>259A9C4C-8DF6-48F9-B626-B414032F4DC8</gtr:id><gtr:firstName>Frank</gtr:firstName><gtr:surname>Nestle</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D96054A8-003E-461F-A987-7275B45FABB3"><gtr:id>D96054A8-003E-461F-A987-7275B45FABB3</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:otherNames>Nicholas</gtr:otherNames><gtr:surname>Barker</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601387"><gtr:id>9536644C-76A0-4B1A-8789-C5827E3C7182</gtr:id><gtr:title>Functional characterisation of the major susceptibility locus (PSORS1) for cutaneous inflammation in psoriasis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601387</gtr:grantReference><gtr:abstractText>Skin presents an essential barrier to environmental triggers capable of preventing challenge to the bodies natural defence mechanisms which includes a sophisticated immune surveillance network. Psoriasis, a life long skin disorder, is amongst a group of common conditions associated with chronic irritation and inflammation. Available evidence points to a fundamental defect in the capacity for barrier protection, dysregulation of the immune network or a combination of these through abnormal communication between skin and immune pathways. In order to develop new and effective therapies, a clear understanding of these processes and the fundamental defects that characterise the risk of developing psoriasis is now required. From a well defined region of the human genome, we have set out a series of studies designed to characterise the primary alterations that generate a very much increased risk disease development. Progress towards more effective ways to prevent or cure psoriasis would be expected to cut both in the short and long term, the heavy burden of chronic inflammation, and thus lead to a significant health and economic benefits compared to the present management of this disorder.</gtr:abstractText><gtr:technicalSummary>Psoriasis, a disorder characterised by chronic cutaneous inflammation is amongst the most significant health care problems in dermatological practice. Our group has been instrumental in the identification and delineation of the location of the major genetic risk factor for disease susceptibility, known as PSORS1 and in describing the critical role of T lymphocytes in disease pathogenesis. In order to correctly target therapeutic strategies that form part of our translational research programme, we now need to precisely identify a) the primary molecular defect underlying PSORS1 conferred susceptibility and b) the cellular types, dysregulation of which are key to disease development. Epithelial (keratinocytes) and lymphoid effector cells are prime candidates, as both are known, from our work in human and model systems, to be critical to disease expression and progression. However, we now need to establish the primacy of these cell types on a more physiological basis in the context of our previous genetic studies. To accomplish this we have established the following set of objectives. (1) We will generate a detailed map of transcriptional activity and regulators, across the PSORS1 major susceptibility genomic interval (~250kb) and relate these findings to underlying genetic variation, (2) we will perform functional studies of the two principle biological candidate genes within this region, namely the Class 1 immune recognition molecule, HLA C and CDSN encoding the epithelial junctional protein, corneodesmosin and (3) we will validate our studies through targeted mutagenesis of the PSORS 1 interval in an established in vivo model system. Taken together, these studies will deliver fundamental insights as to the aetiology of common chronic cutaneous inflammation and define the relationship between epithelial and lymphoid dysregulation that leads to the development of psoriasis.</gtr:technicalSummary><gtr:fund><gtr:end>2012-07-22</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-07-23</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1561134</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Fios Genomics</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MAARS</gtr:description><gtr:id>019A05C9-A40D-4C2B-A165-65DD3974A4F4</gtr:id><gtr:impact>5.9 million euros funding from the EU to the MAARS Consortium, where King's College London is represented by Profs Barker and Nestle (both co-investigators in the MRC G0601387 grant)</gtr:impact><gtr:outcomeId>ADWZyyvDfJc-6</gtr:outcomeId><gtr:partnerContribution>Microbiome sequencing; transcriptomics</gtr:partnerContribution><gtr:piContribution>In-vivo and in-vitro functional assays</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kiel</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>psoriasis immunochip consortium</gtr:description><gtr:id>7A2F2107-6F97-4213-B8C3-43D440E1612F</gtr:id><gtr:impact>identification of psoriasis relevant variants to include on the Immunochip</gtr:impact><gtr:outcomeId>nCUMDr9esDR-2</gtr:outcomeId><gtr:partnerContribution>data and information sharingdata and information sharing</gtr:partnerContribution><gtr:piContribution>data and information sharing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PSORT</gtr:description><gtr:id>9BB56AF6-77AD-4011-BC4F-77C6BEEB9C47</gtr:id><gtr:impact>MRC Stratified Medicine grant</gtr:impact><gtr:outcomeId>L3xP3XVs9wM-1</gtr:outcomeId><gtr:partnerContribution>Patient recruitment and phenotyping; transcriptomic analysis.</gtr:partnerContribution><gtr:piContribution>Genotyping and data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Heinrich Heine University D?sseldorf</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>MAARS</gtr:description><gtr:id>1D939524-C7F3-40F8-9E37-2685E84E59D5</gtr:id><gtr:impact>5.9 million euros funding from the EU to the MAARS Consortium, where King's College London is represented by Profs Barker and Nestle (both co-investigators in the MRC G0601387 grant)</gtr:impact><gtr:outcomeId>ADWZyyvDfJc-3</gtr:outcomeId><gtr:partnerContribution>Microbiome sequencing; transcriptomics</gtr:partnerContribution><gtr:piContribution>In-vivo and in-vitro functional assays</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hebrew University of Jerusalem</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>MAARS</gtr:description><gtr:id>7EFC5B30-C627-4324-A20B-EB7F3EFD2EC1</gtr:id><gtr:impact>5.9 million euros funding from the EU to the MAARS Consortium, where King's College London is represented by Profs Barker and Nestle (both co-investigators in the MRC G0601387 grant)</gtr:impact><gtr:outcomeId>ADWZyyvDfJc-2</gtr:outcomeId><gtr:partnerContribution>Microbiome sequencing; transcriptomics</gtr:partnerContribution><gtr:piContribution>In-vivo and in-vitro functional assays</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Michigan</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>psoriasis immunochip consortium</gtr:description><gtr:id>38B95033-39A2-4E31-BDA4-6133DF23526F</gtr:id><gtr:impact>identification of psoriasis relevant variants to include on the Immunochip</gtr:impact><gtr:outcomeId>nCUMDr9esDR-1</gtr:outcomeId><gtr:partnerContribution>data and information sharingdata and information sharing</gtr:partnerContribution><gtr:piContribution>data and information sharing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Icosagen</gtr:collaboratingOrganisation><gtr:country>Estonia, Republic of</gtr:country><gtr:description>MAARS</gtr:description><gtr:id>35896C3D-92A4-4230-B731-830727917E91</gtr:id><gtr:impact>5.9 million euros funding from the EU to the MAARS Consortium, where King's College London is represented by Profs Barker and Nestle (both co-investigators in the MRC G0601387 grant)</gtr:impact><gtr:outcomeId>ADWZyyvDfJc-5</gtr:outcomeId><gtr:partnerContribution>Microbiome sequencing; transcriptomics</gtr:partnerContribution><gtr:piContribution>In-vivo and in-vitro functional assays</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kiel</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>MAARS</gtr:description><gtr:id>047B2A2E-7CB3-44BF-84F7-52EE84870051</gtr:id><gtr:impact>5.9 million euros funding from the EU to the MAARS Consortium, where King's College London is represented by Profs Barker and Nestle (both co-investigators in the MRC G0601387 grant)</gtr:impact><gtr:outcomeId>ADWZyyvDfJc-4</gtr:outcomeId><gtr:partnerContribution>Microbiome sequencing; transcriptomics</gtr:partnerContribution><gtr:piContribution>In-vivo and in-vitro functional assays</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Neurological Surgery</gtr:department><gtr:description>UCSF</gtr:description><gtr:id>90B5351F-7B05-4210-8F23-B7A942E2C272</gtr:id><gtr:impact>experimental work still under way.</gtr:impact><gtr:outcomeId>PbzNkr82uqk-1</gtr:outcomeId><gtr:partnerContribution>training in experimental and analysis techniques</gtr:partnerContribution><gtr:piContribution>experimental work and design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PSORT</gtr:description><gtr:id>FB2791E1-CA01-40A7-92EB-35DFF05EA4E5</gtr:id><gtr:impact>MRC Stratified Medicine grant</gtr:impact><gtr:outcomeId>L3xP3XVs9wM-5</gtr:outcomeId><gtr:partnerContribution>Patient recruitment and phenotyping; transcriptomic analysis.</gtr:partnerContribution><gtr:piContribution>Genotyping and data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>MAARS</gtr:description><gtr:id>7C91628E-1F83-4498-A2E3-AD77AFF5184A</gtr:id><gtr:impact>5.9 million euros funding from the EU to the MAARS Consortium, where King's College London is represented by Profs Barker and Nestle (both co-investigators in the MRC G0601387 grant)</gtr:impact><gtr:outcomeId>ADWZyyvDfJc-1</gtr:outcomeId><gtr:partnerContribution>Microbiome sequencing; transcriptomics</gtr:partnerContribution><gtr:piContribution>In-vivo and in-vitro functional assays</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Dana-Farber Cancer Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>The impact of Histone deacetylation inhibition on inflammation</gtr:description><gtr:id>0FC9E0A8-1444-4D84-B050-4810209FA8B9</gtr:id><gtr:impact>replication of results underway</gtr:impact><gtr:outcomeId>dRSXaWWgLhU-1</gtr:outcomeId><gtr:partnerContribution>intellectual and experimental input</gtr:partnerContribution><gtr:piContribution>testing HDACi in a mouse model of inflammation</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Michigan</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>GAIN psoriasis consortium</gtr:description><gtr:id>D6586E71-F042-497F-A710-B88D53B9D27A</gtr:id><gtr:impact>As a new collaboration this is yet to produce outcomes</gtr:impact><gtr:outcomeId>bPZK7Hngy4o-1</gtr:outcomeId><gtr:partnerContribution>sharing of data resourcessharing of data resources</gtr:partnerContribution><gtr:piContribution>planning of experimental design and analyitcal development platforms</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PSORT</gtr:description><gtr:id>EDED8AE2-01E1-4DA1-A995-C017B024BBF0</gtr:id><gtr:impact>MRC Stratified Medicine grant</gtr:impact><gtr:outcomeId>L3xP3XVs9wM-2</gtr:outcomeId><gtr:partnerContribution>Patient recruitment and phenotyping; transcriptomic analysis.</gtr:partnerContribution><gtr:piContribution>Genotyping and data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Psoriasis Association</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PSORT</gtr:description><gtr:id>2B058DA7-1152-4415-BEA8-23B24ADB69CC</gtr:id><gtr:impact>MRC Stratified Medicine grant</gtr:impact><gtr:outcomeId>L3xP3XVs9wM-4</gtr:outcomeId><gtr:partnerContribution>Patient recruitment and phenotyping; transcriptomic analysis.</gtr:partnerContribution><gtr:piContribution>Genotyping and data analysis</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>PSORT</gtr:description><gtr:id>4AFF76EF-9554-410D-9520-C7A3B6CD6B07</gtr:id><gtr:impact>MRC Stratified Medicine grant</gtr:impact><gtr:outcomeId>L3xP3XVs9wM-3</gtr:outcomeId><gtr:partnerContribution>Patient recruitment and phenotyping; transcriptomic analysis.</gtr:partnerContribution><gtr:piContribution>Genotyping and data analysis</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Statistics (QMUL)</gtr:department><gtr:description>Van Heel</gtr:description><gtr:id>AC0B72D8-DD0D-466F-9D31-CE363670D0CF</gtr:id><gtr:impact>Article by Hunt et al, recently published on Nature</gtr:impact><gtr:outcomeId>B83fCX59x7p-1</gtr:outcomeId><gtr:partnerContribution>Study design and data generation</gtr:partnerContribution><gtr:piContribution>DNA samples, data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust Case Control Consortium 2 (WTCCC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>WTCCC2</gtr:description><gtr:id>3E0EC9FA-0B6E-4C04-A4DC-6327A8084404</gtr:id><gtr:impact>Joint publications
Strange et al, Nat Genet. 2010 Nov;42(11):985-90. Epub 2010 Oct 17.PMID: 20953190 
Tsoi et al, Nat Genet. 2012 Nov 11. doi: 10.1038/ng.2467. [Epub ahead of print] PMID: 23143594</gtr:impact><gtr:outcomeId>BHV9BQer9Yr-1</gtr:outcomeId><gtr:partnerContribution>Genotyping, analysis, expertise</gtr:partnerContribution><gtr:piContribution>Samples, analysis, expertise</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kiel</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>GAIN psoriasis consortium</gtr:description><gtr:id>8B3E5464-19CB-4F83-8FC8-56272760DE15</gtr:id><gtr:impact>As a new collaboration this is yet to produce outcomes</gtr:impact><gtr:outcomeId>bPZK7Hngy4o-2</gtr:outcomeId><gtr:partnerContribution>sharing of data resourcessharing of data resources</gtr:partnerContribution><gtr:piContribution>planning of experimental design and analyitcal development platforms</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>biomedical research forum</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F08D72FB-FC3A-4AC9-A17E-68E75112B01F</gtr:id><gtr:impact>NIHR Biomedical Research Centre - monthly open access presentation transmitted to 4 sites in London and internationally.

increased awareness of aims of research</gtr:impact><gtr:outcomeId>QK9GaQpfeM7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>cafe scientifique</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>67502232-DB31-421E-84E1-9E914CF8C6ED</gtr:id><gtr:impact>short presentation to members of the public at the Biomedical Research Centre cafe scientifique event at Guy's Hospital, London. Questions and discussions followed

Positive feed back received</gtr:impact><gtr:outcomeId>ATtQ6jnm8rf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>207536</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC clinical training fellowship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>91DCCD40-E39C-47FE-9FFB-0B37A43014CC</gtr:id><gtr:outcomeId>CyVqD28C9UX0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>231159</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC clinical training fellowship</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>EDEB3F84-5B20-43E9-B4F2-16C822CB9E93</gtr:id><gtr:outcomeId>ZVHKqwChwJp0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>81000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentships</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>British Skin Foundation</gtr:fundingOrg><gtr:fundingRef>3007s</gtr:fundingRef><gtr:id>87D39401-2937-4E66-AD19-D2B765373380</gtr:id><gtr:outcomeId>aqQgPQx8T9q</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Psoriasis Association PhD studentship</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>The Psoriasis Association</gtr:fundingOrg><gtr:id>ED36134E-86D3-4526-81EA-959FE0642A06</gtr:id><gtr:outcomeId>SuW7JJ6i5qo</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Stratified Medicine award</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L011808/1</gtr:fundingRef><gtr:id>792B731E-52A2-4765-9F62-0D69499EF22E</gtr:id><gtr:outcomeId>YB1RJG9MqAe</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>199657</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F503378D-A2BF-461C-98C5-30CED46BDE70</gtr:id><gtr:outcomeId>MW3ET2bZxGq</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>244510</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>4CB0C4AF-C55A-4392-A987-771E823C12D9</gtr:id><gtr:outcomeId>RonrtEMqztD</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>HLA-C allele specific reporter constructs</gtr:description><gtr:id>A0F3BEF4-C43D-4839-9E41-8BD45DB3F5DB</gtr:id><gtr:impact>identification of a promoter variant mediating reduced responsiveness to TNF-a</gtr:impact><gtr:outcomeId>nFjgCnkHc4s</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>HLA-C promoter constructs</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>generation of a series of BAC library which harbours using DNA derived from an individual heterozygous for the HLA-Cw0602 risk allele for psoriasis</gtr:description><gtr:id>B43A2809-730F-4FB1-BFBD-E0D1727E7AAA</gtr:id><gtr:impact>Allowed detailed analysis of potential causal variants responsible for the susceptibility to psoriasis associated with this locus.</gtr:impact><gtr:outcomeId>B4eUtNHx84e</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>BACS</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Design of MHC specific array for targeted bisulphite next generation sequencing (NGS) and optimisation of NGS techniques and analysis for application to this specific protocol</gtr:description><gtr:id>50D4A5AA-11B5-44D6-98E3-67565A04C730</gtr:id><gtr:impact>Successful application of this technique to the highly variable MHC region</gtr:impact><gtr:outcomeId>mu3gRchBqby</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>bisulphite NGS</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>SNP array designed to include variants relevant to immunological disease including variants identified through this project to be potential causal variants in psoriasis</gtr:description><gtr:id>9A649D11-0523-42A4-8EC7-5742963A7AE0</gtr:id><gtr:impact>experimental work currently on going.</gtr:impact><gtr:outcomeId>BB9EpBwL13L</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>immunochip</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Two Immortalized keratinocyte cell lines where a gene associated with pustular psoriasis has been knocked down by lentiviral shRNA transduction</gtr:description><gtr:id>C069E8A1-BC5F-4582-BF2E-0C03CD575075</gtr:id><gtr:impact>The characterization of the cellular phenotype will be included in a gene identification manuscript, which is currently in preparation.</gtr:impact><gtr:outcomeId>fdZVSpPCHrL</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>knockdown cell lines</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9A83F1E1-20F2-4CB1-873C-69621EE129B0</gtr:id><gtr:title>Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/570799dafea994d041cee77644b69946"><gtr:id>570799dafea994d041cee77644b69946</gtr:id><gtr:otherNames>Sagoo P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>pm_15776_26_21593402</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6DBE400-214E-4C9E-806E-E18E48DE0631</gtr:id><gtr:title>Loss of IL36RN function does not confer susceptibility to psoriasis vulgaris.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63ae76b4f1c61968e746a1ce67901b5b"><gtr:id>63ae76b4f1c61968e746a1ce67901b5b</gtr:id><gtr:otherNames>Berki DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>pm_15776_26_23792462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42E6FEE8-9605-4E6E-BB14-BAA3A7570836</gtr:id><gtr:title>Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/452992ec96450d25ae860677ec8c019a"><gtr:id>452992ec96450d25ae860677ec8c019a</gtr:id><gtr:otherNames>Riveira-Munoz E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>mCD31gfWrXR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B5EE44F-45B6-43E9-8B5C-50D76444F2D2</gtr:id><gtr:title>Xenogeneic graft-versus-host-disease in NOD-scid IL-2R?null mice display a T-effector memory phenotype.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d2d26172d8e85835cd23e1b4463a75c"><gtr:id>8d2d26172d8e85835cd23e1b4463a75c</gtr:id><gtr:otherNames>Ali N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15776_26_22937164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BC90008-56E4-413F-9A12-A7BAC7ED752F</gtr:id><gtr:title>The IL23R A/Gln381 allele promotes IL-23 unresponsiveness in human memory T-helper 17 cells and impairs Th17 responses in psoriasis patients.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e88821cf25005216ad94d24a572ef57"><gtr:id>0e88821cf25005216ad94d24a572ef57</gtr:id><gtr:otherNames>Di Meglio P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>pm_15776_26_23563201</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99FEB0E3-2FB7-4D8C-9AC7-1C354A4B3AB7</gtr:id><gtr:title>Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetes.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a834ac21f442dbdd8b1e0d5a8e871a7"><gtr:id>5a834ac21f442dbdd8b1e0d5a8e871a7</gtr:id><gtr:otherNames>Quaranta M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>npq6FEKi9Pb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>186CCAD9-E161-4488-B5EC-2F9895C0C3EE</gtr:id><gtr:title>Generalized pustular eruptions: time to adapt the disease taxonomy to the genetic architecture?</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ea122c6c4d9a15b408bd3b917a5dc5b"><gtr:id>0ea122c6c4d9a15b408bd3b917a5dc5b</gtr:id><gtr:otherNames>Navarini AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>pm_15776_26_23955072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE5EB16F-9B74-47A3-A0E8-FA5FDC3FBB59</gtr:id><gtr:title>The multitasking organ: recent insights into skin immune function.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e88821cf25005216ad94d24a572ef57"><gtr:id>0e88821cf25005216ad94d24a572ef57</gtr:id><gtr:otherNames>Di Meglio P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>pm_15776_26_22195743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FD4D74B-F78D-4315-89CC-FB4753D4D859</gtr:id><gtr:title>The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e88821cf25005216ad94d24a572ef57"><gtr:id>0e88821cf25005216ad94d24a572ef57</gtr:id><gtr:otherNames>Di Meglio P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>260FABB8_7260FABB8_7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>828459E2-4164-416D-ABBF-267661183CF5</gtr:id><gtr:title>The quest for psoriasis susceptibility genes in the postgenome-wide association studies era: charting the road ahead.</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f2e4ca853cd65895743353f76fa758a"><gtr:id>2f2e4ca853cd65895743353f76fa758a</gtr:id><gtr:otherNames>Capon F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn><gtr:outcomeId>pm_15776_26_22626038</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32A8E98E-FF1F-4EFF-B041-801EC7B91EA9</gtr:id><gtr:title>Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67eedf5da41373304ac2b73f6eac5be6"><gtr:id>67eedf5da41373304ac2b73f6eac5be6</gtr:id><gtr:otherNames>Wolf N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>fk54fzRnBrT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2266DE90-3650-4B23-8AD7-A8DCAA185E12</gtr:id><gtr:title>The role of IL-23 in the immunopathogenesis of psoriasis.</gtr:title><gtr:parentPublicationTitle>F1000 biology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e88821cf25005216ad94d24a572ef57"><gtr:id>0e88821cf25005216ad94d24a572ef57</gtr:id><gtr:otherNames>Di Meglio P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1757-594X</gtr:issn><gtr:outcomeId>PyGNJsLHQFf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01BB231E-AEEF-46FA-A5CE-77127408B9F1</gtr:id><gtr:title>Progress in understanding the immunopathogenesis of psoriasis.</gtr:title><gtr:parentPublicationTitle>Actas dermo-sifiliograficas</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be2f7c1c16bf7bf5c872c4d005633c74"><gtr:id>be2f7c1c16bf7bf5c872c4d005633c74</gtr:id><gtr:otherNames>Mak RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0001-7310</gtr:issn><gtr:outcomeId>179A85E7_E179A85E7_E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5C13BF2-0956-4519-811F-F9806816AA4C</gtr:id><gtr:title>A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46d831ce8ae2662e3d42bdf88c194555"><gtr:id>46d831ce8ae2662e3d42bdf88c194555</gtr:id><gtr:otherNames>Genetic Analysis of Psoriasis Consortium &amp; the Wellcome Trust Case Control Consortium 2</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>kUGgRe319nZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61D566E5-8B1E-41F9-BAA2-85E512B2F2AA</gtr:id><gtr:title>Integrative biology approach identifies cytokine targeting strategies for psoriasis.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc10ec43a1dbe3971bd763b8649463aa"><gtr:id>bc10ec43a1dbe3971bd763b8649463aa</gtr:id><gtr:otherNames>Perera GK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>pm_540e14fe14f47d60f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>357B4C78-E376-4C08-81DA-4AC05426C12C</gtr:id><gtr:title>Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ea122c6c4d9a15b408bd3b917a5dc5b"><gtr:id>0ea122c6c4d9a15b408bd3b917a5dc5b</gtr:id><gtr:otherNames>Navarini AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>pm_15776_26_23358093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5775BEBA-7B02-4634-A5CD-364EDFF988FC</gtr:id><gtr:title>Identification of rare, disease-associated variants in the promoter region of the RNF114 psoriasis susceptibility gene.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5be4ce2b5f5c5ade413d93e9bf3a28b3"><gtr:id>5be4ce2b5f5c5ade413d93e9bf3a28b3</gtr:id><gtr:otherNames>Onoufriadis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>pm_15776_26_22205304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93B5C4FA-3EE6-4108-987E-9F62E9C74C17</gtr:id><gtr:title>Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6047fd0721697bdc6a55160312ae7c08"><gtr:id>6047fd0721697bdc6a55160312ae7c08</gtr:id><gtr:otherNames>Setta-Kaffetzi N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>pm_15776_26_23303454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17E24CAB-3ADC-4BE3-A5DB-2B979B5B72B4</gtr:id><gtr:title>Negligible impact of rare autoimmune-locus coding-region variants on missing heritability.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28d5e44cfd0fb461260062e89bab9868"><gtr:id>28d5e44cfd0fb461260062e89bab9868</gtr:id><gtr:otherNames>Hunt KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15776_26_23698362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAF10591-6156-448D-A1D5-C831E92AF9D9</gtr:id><gtr:title>Skin immune sentinels in health and disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d6b60a87759b5b9207115fc2ff23061"><gtr:id>9d6b60a87759b5b9207115fc2ff23061</gtr:id><gtr:otherNames>Nestle FO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>1629677D_11629677D_1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93E378F0-FA75-46C7-91D1-A84CBCE8F2EB</gtr:id><gtr:title>Psoriasis.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d6b60a87759b5b9207115fc2ff23061"><gtr:id>9d6b60a87759b5b9207115fc2ff23061</gtr:id><gtr:otherNames>Nestle FO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_15776_16_19641206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4DE1888-936A-4C21-964C-918A5192E201</gtr:id><gtr:title>Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54a4658ef858b411d66e115aaf52aba8"><gtr:id>54a4658ef858b411d66e115aaf52aba8</gtr:id><gtr:otherNames>Tsoi LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_15776_26_23143594</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67D11737-E242-4E3E-B14D-C6C60A69625D</gtr:id><gtr:title>A systems model for immune cell interactions unravels the mechanism of inflammation in human skin.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8b410803d73ae6b0d43a2b900a929b7"><gtr:id>a8b410803d73ae6b0d43a2b900a929b7</gtr:id><gtr:otherNames>Valeyev NV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>pm_15776_26_21152006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DB69879-39AD-48EA-AB50-13123D096549</gtr:id><gtr:title>Harnessing dendritic cells in inflammatory skin diseases.</gtr:title><gtr:parentPublicationTitle>Seminars in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02ae69f7069edf41f415e75af614477f"><gtr:id>02ae69f7069edf41f415e75af614477f</gtr:id><gtr:otherNames>Chu CC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1044-5323</gtr:issn><gtr:outcomeId>pm_15776_26_21295490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1CAD48B-112D-4BA2-99A7-3001E8324551</gtr:id><gtr:title>Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02ae69f7069edf41f415e75af614477f"><gtr:id>02ae69f7069edf41f415e75af614477f</gtr:id><gtr:otherNames>Chu CC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>pm_15776_26_22547651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2E14F6F-B8E5-4295-BF46-31CE4FF4B177</gtr:id><gtr:title>Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43d0d23737bcf164813e93f774577d3e"><gtr:id>43d0d23737bcf164813e93f774577d3e</gtr:id><gtr:otherNames>UK IBD Genetics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>92373984852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C8FED9E-11EC-4533-9527-FA4AC97B11F8</gtr:id><gtr:title>Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5be4ce2b5f5c5ade413d93e9bf3a28b3"><gtr:id>5be4ce2b5f5c5ade413d93e9bf3a28b3</gtr:id><gtr:otherNames>Onoufriadis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>hsFQE6MUSC2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C1328DD-7A76-4607-8CD3-420A29E76602</gtr:id><gtr:title>Unraveling the autoimmune translational research process layer by layer.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6eacd85cd95c31e69b2a37ae2009d0d4"><gtr:id>6eacd85cd95c31e69b2a37ae2009d0d4</gtr:id><gtr:otherNames>Blumberg RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>pm_15776_26_22227670</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BFD17EB-A90B-4033-9D38-BDBAEB0BFA2A</gtr:id><gtr:title>Psoriasis and other complex trait dermatoses: from Loci to functional pathways.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f2e4ca853cd65895743353f76fa758a"><gtr:id>2f2e4ca853cd65895743353f76fa758a</gtr:id><gtr:otherNames>Capon F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>pm_15776_26_22158561</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F70079D-4B01-4E3E-8399-C29AE8DD4656</gtr:id><gtr:title>Skin immune surveillance by T cells--a new order?</gtr:title><gtr:parentPublicationTitle>Seminars in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6c672f701d0cce2018591c75b1b388f"><gtr:id>f6c672f701d0cce2018591c75b1b388f</gtr:id><gtr:otherNames>Strid J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1044-5323</gtr:issn><gtr:outcomeId>pm_15776_16_19369094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CE31BC3-D971-445F-8A58-1864252224B5</gtr:id><gtr:title>Identification of a novel proinflammatory human skin-homing V?9Vd2 T cell subset with a potential role in psoriasis.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87b47e0837770cbfc46cfe6ffbaf48eb"><gtr:id>87b47e0837770cbfc46cfe6ffbaf48eb</gtr:id><gtr:otherNames>Laggner U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>L3Tn2TDEbr7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49907452-3140-4A18-9EE6-C4C5482FF1ED</gtr:id><gtr:title>Conditional analysis identifies three novel major histocompatibility complex loci associated with psoriasis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccf4169893a11ab3549158dd95501784"><gtr:id>ccf4169893a11ab3549158dd95501784</gtr:id><gtr:otherNames>Knight J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_15776_26_22914738</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F00E79D9-CA4F-45F6-BF55-B4F584AF598D</gtr:id><gtr:title>Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing ?d cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f42985a34492062e94b69bb5c200fe9"><gtr:id>1f42985a34492062e94b69bb5c200fe9</gtr:id><gtr:otherNames>Michel ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15776_26_23047700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A24363B4-7859-4AFF-8118-ED389A8426D1</gtr:id><gtr:title>Psoriasis.</gtr:title><gtr:parentPublicationTitle>Annual review of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc10ec43a1dbe3971bd763b8649463aa"><gtr:id>bc10ec43a1dbe3971bd763b8649463aa</gtr:id><gtr:otherNames>Perera GK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-4006</gtr:issn><gtr:outcomeId>pm_15776_26_22054142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03F1D5CF-1C62-42CF-8327-1119CD034191</gtr:id><gtr:title>Gammadelta T cells and the lymphoid stress-surveillance response.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae7e1471075c2e61ef05e8cf6a6b7daa"><gtr:id>ae7e1471075c2e61ef05e8cf6a6b7daa</gtr:id><gtr:otherNames>Hayday AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>pm_15776_16_19699170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD120801-0A0A-403B-B242-4D4262F2379E</gtr:id><gtr:title>Innate responsiveness of CD8 memory T-cell populations nonspecifically inhibits allergic sensitization.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2467c317ae8aaa11255758b0d6229da8"><gtr:id>2467c317ae8aaa11255758b0d6229da8</gtr:id><gtr:otherNames>Leggat JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>aMExWrptFvw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>692069F5-4C8B-4FB1-80D5-2115377C08AF</gtr:id><gtr:title>An in-depth characterization of the major psoriasis susceptibility locus identifies candidate susceptibility alleles within an HLA-C enhancer element.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f2beecc654188532eca8f52824de7df"><gtr:id>9f2beecc654188532eca8f52824de7df</gtr:id><gtr:otherNames>Clop A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15776_26_23990973</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>546982FE-7966-45AF-86FF-8132A6FAE202</gtr:id><gtr:title>Allele-specific cytokine responses at the HLA-C locus: implications for psoriasis.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e3b737d0ea2544de2265840885f103"><gtr:id>c5e3b737d0ea2544de2265840885f103</gtr:id><gtr:otherNames>Hundhausen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>Zwxu6PVKuNN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F34ED6B8-A063-4364-9E89-ED84956C6B61</gtr:id><gtr:title>Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f2e4ca853cd65895743353f76fa758a"><gtr:id>2f2e4ca853cd65895743353f76fa758a</gtr:id><gtr:otherNames>Capon F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>197476E8FA7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D26E157E-943A-4546-86FD-631BE4A69F8B</gtr:id><gtr:title>Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/659a90764cdbc1c1731e59ad25529701"><gtr:id>659a90764cdbc1c1731e59ad25529701</gtr:id><gtr:otherNames>Bijlmakers MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>WhjqdLjtJfJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B25ACA53-75A2-4C55-A776-970728FDEDCF</gtr:id><gtr:title>Cutting edge: A critical functional role for IL-23 in psoriasis.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e18a5c3d0a780f548d7ab690831c869d"><gtr:id>e18a5c3d0a780f548d7ab690831c869d</gtr:id><gtr:otherNames>Tonel G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>QpX7PFiGMDg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6A04916-AA5D-40BC-B0C3-D221ED173DB4</gtr:id><gtr:title>The IL-23/Th17 axis in the immunopathogenesis of psoriasis.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/299911d2a73a5334c02cfc03ffe5613b"><gtr:id>299911d2a73a5334c02cfc03ffe5613b</gtr:id><gtr:otherNames>Di Cesare A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>pm_15776_16_19322214</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601387</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7EE9741E-CF94-420A-B0AB-A7811523CF2C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Skin</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>